AEON Biopharma, Inc.

AEON
$0.70 (+ $0.00 + 0.07%)
Last updated: 2026-07-08 21:16 UTC
AEON Metrics
Exchange
🇺🇸 NYSE XASE
NYSE Mkt LLCUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS00791X2099
CUSIP00791X209
Market Price0.7
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.35
EPS2.98
Market Cap$14.2M
Book Value-1.71
Price to Book-0.603
Beta0.75
52w High45.29
52w Low0.38
Next Earnings DateN/A

AEON Biopharma, Inc. trades under ticker AEON on NYSE as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US00791X2099, CUSIP 00791X209.

About the Company
AEON Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine, as well as develops ABP-450 for the treatment of gastroparesis and post-traumatic stress disorder. The company has license agreements Daewoong Pharmaceutical Co., LTD., and Viatris Inc. The company is based in Irvine, California.
Price History